Appkit 125mg/80mg Capsule
Marketer
Hilfen Pharmaceuticals Pvt Ltd
Salt Composition
Aprepitant (125mg) + Aprepitant (80mg)
Overview Appkit 125mg/80mg Capsule
Oncas 125mg/80mg capsules are a prescription medication indicated for managing chemotherapy-induced nausea and vomiting. This medication works by blocking the signals to the brain responsible for triggering these symptoms. Oncas 125mg/80mg capsules should be taken as directed by your physician, with or without food. Dosage and treatment length are determined by your individual needs and response. Complete the prescribed course; premature discontinuation may lead to symptom recurrence and condition exacerbation. Inform your doctor of all other medications you are using, as interactions are possible. Common side effects include constipation, dyspepsia, headache, fatigue, anorexia, and hiccups; most are transient. Report any concerning side effects immediately. Drowsiness and dizziness are possible; avoid driving or activities requiring alertness until the effects are known. Alcohol consumption should be avoided due to increased drowsiness risk. Before starting treatment, disclose any pregnancy, pregnancy plans, or breastfeeding.
Primary Ingredients of Appkit 125mg/80mg Capsule
No information provided. Please provide the text you wish me to rephrase.
Uses of Appkit 125mg/80mg Capsule
Chemotherapy-induced emesis
Major Benefits of Appkit 125mg/80mg Capsule:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Appkit 125mg/80mg Capsules can be administered with or without food; however, consistent timing is recommended.
Common Side effects of Appkit 125mg/80mg Capsule:
- Constipation
- Indigestion
- Headache
- Tiredness
- Loss of appetite
- Hiccup
- Increased liver enzymes
How to use Appkit 125mg/80mg Capsule:
Follow your doctor's instructions precisely regarding dosage and treatment length for Appkit 125mg/80mg Capsules. These capsules can be ingested with or without food, though consistent timing is recommended.
How Appkit 125mg/80mg Capsule works:
Aprepitant dual-dose capsules (Appkit 125mg/80mg) combine two strengths of the active ingredient to counteract chemotherapy-induced nausea and vomiting. This medication achieves its effect by inhibiting a neurotransmitter in the brain responsible for these side effects.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Appkit 125mg/80mg Capsules may pose unknown risks. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
Data on the use of Appkit 125mg/80mg capsules in pregnancy is lacking. Seek medical advice from your physician.
Breast feedingCONSULT YOUR DOCTOR
The use of Appkit 125mg/80mg capsules while breastfeeding is likely inadvisable. Available human data indicates potential drug transfer into breast milk, posing a possible risk to the infant.
DrivingUNSAFE
Taking Appkit 125mg/80mg capsules can lead to drowsiness, blurred vision, or dizziness. Refrain from driving if you experience these effects.
KidneySAFE IF PRESCRIBED
The 125mg/80mg Appkit capsule presents no need for dosage modification in individuals with renal impairment and is considered safe for their use.
LiverSAFE IF PRESCRIBED
The use of Appkit 125mg/80mg Capsules in individuals with hepatic impairment is likely safe. Preliminary evidence indicates dose modification may be unnecessary, however, physician consultation is recommended.
What if you forget to take Appkit 125mg/80mg Capsule :
Should you forget to take a dose of Appkit 125mg/80mg Capsule, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Appkit 125mg/80mg Capsule
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Gastrointestinal system |
3,018 People bought this recently